Lung cancer screening intervals based on cancer risk

被引:4
|
作者
Zhang, Li [1 ,2 ]
Yip, Rowena [2 ]
Jirapatnakul, Artit [2 ]
Li, Meng [1 ,2 ]
Cai, Qiang [2 ,3 ]
Henschke, Claudia, I [2 ,4 ]
Yankelevitz, David F. [2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Diagnost Radiol, Natl Canc Ctr, Natl Clin Res Ctr,Canc Canc Hosp, Beijing 100021, Peoples R China
[2] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
[3] Shanxi Prov Peoples Hosp, Dept Radiol, Taiyuan 030012, Shanxi, Peoples R China
[4] Vet Adm Hlth Care Syst, Phoenix, AZ USA
关键词
Volume doubling time; Tumor aggressiveness; Risk prediction model; CT screening; PULMONARY NODULES; CT; TRIAL; MORTALITY; PROBABILITY; BENEFITS;
D O I
10.1016/j.lungcan.2020.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: As low-dose CT screening is gaining acceptance, focus is on increasing the efficiency of screening. One major consideration is to reduce the total number of annual rounds by increasing the interval between screening rounds. It has been suggested that longer intervals could be used for individuals who are at lower risk of lung cancer. In this study, we explored whether eligible participants in a program of LDCT screening who are at lower risk of lung cancer have less aggressive cancers than those at higher risk. Methods: We retrospectively identified 118 participants in I-ELCAP database between 1992-2019 who had been screened using HIPAA-compliant protocols and had solid lung cancers diagnosed on an annual round of screening, 7-18 months after the prior round. Volume doubling time (VDT) for each cancer was calculated. Estimated risk of developing lung cancer was calculated using PLCOM2012 model. The strength of the relationship between VDT and individual PLCOM2012 scores was assessed by Pearson(r) and Spearman (rho) correlation coefficients. Results: VDTs were significantly different by cell-type (p < 0.0001); median VDT for small cell was 34.0 days, followed by other cell-types (61.8 days), squamous-cell (73.3 days), and adenocarcinoma (135.7 days). The median VDT for the 78 (66.1 %) Stage I lung cancers was significantly longer than the 40 Stage II + lung cancers (101.4 days vs. 45.5 days, p < 0.0001). None of the established lung cancer risk indicators (age, pack-years of smoking, or PLCOM2012 scores) were significant predictors of VDT or lung cancer stage. Conclusion: No significant relationship was demonstrated between risk of developing lung cancer (measured by risk models, age or smoking history) and lung cancer aggressiveness (measured by VDT, cell-type and Stage). This suggests that there is no evidence for determining intervals between repeat screenings using risk-based characteristics. It does not, however, exclude the possibility that future models may establish such a relationship.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [1] Lung cancer screening: screening frequency and lung cancer risk
    Manser, Renee L.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1227 - S1232
  • [2] Risk model-based lung cancer screening
    Nierengarten, Mary Beth
    [J]. CANCER, 2023, 129 (11) : 1628 - 1628
  • [3] LDCT lung cancer screening in populations at different risk for lung cancer
    da Silva Teles, Gustavo Borges
    Sandoval Macedo, Ana Carolina
    Chate, Rodrigo Caruso
    Tabone Valente, Viviane Arevalo
    de Gusmao Funari, Marcelo Buarque
    Szarf, Gilberto
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [4] Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works
    Jett, James R.
    Midthun, David E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 155 (08) : 540 - 542
  • [5] The role of lung cancer risk and comorbidity in lung cancer screening use
    Richman, Ilana B.
    Long, Jessica B.
    Poghosyan, Hermine
    Sather, Polly
    Gross, Cary P.
    [J]. PREVENTIVE MEDICINE REPORTS, 2022, 30
  • [6] A risk model for lung cancer screening
    Sharp, Charles
    [J]. THORAX, 2013, 68 (09) : 893 - 893
  • [7] Radiation Risk of Lung Cancer Screening
    Frank, Luba
    Christodoulou, Emmanuel
    Kazerooni, Ella A.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 738 - 747
  • [8] Risk-Based lung cancer screening: A systematic review
    Toumazis, Iakovos
    Bastani, Mehrad
    Han, Summer S.
    Plevritis, Sylvia K.
    [J]. LUNG CANCER, 2020, 147 : 154 - 186
  • [9] Risk stratification based on screening history: the NELSON lung cancer screening study
    Yousaf-Khan, Uraujh
    van der Aalst, Carlijn
    de Jong, Pim A.
    Heuvelmans, Marjolein
    Scholten, Ernst
    Walter, Joan
    Nackaerts, Kristiaan
    Groen, Harry
    Vliegenthart, Rozemarijn
    ten Haaf, Kevin
    Oudkerk, Matthijs
    de Koning, Harry
    [J]. THORAX, 2017, 72 (09) : 819 - 824
  • [10] Appropriate screening intervals in low-dose CT lung cancer screening
    Heuvelmans, Marjolein A.
    Oudkerk, Matthijs
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) : 281 - 287